Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Grolleau

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancers|March 25, 2022
Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World StudyJean-Baptiste Assié, Florian Crépin, Emmanuel Grolleau, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2025
The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapyCaroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, et al.
Biomolecules|August 26, 2023
Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular ProfilingEmmanuel Grolleau, Julie Candiracci, Gaelle Lescuyer, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2024
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trialOlivier Bylicki, Florian Guisier, Arnaud Scherpereel, et al.
Tobacco Prevention & Cessation|July 16, 2021
Tobacco use and related behaviors among staff and students in a university hospital: A large cross-sectional surveyEmmanuel Grolleau, Véronique Fonteille, Caroline Lebourgeois, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancers|March 25, 2022
Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World StudyJean-Baptiste Assié, Florian Crépin, Emmanuel Grolleau, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2025
The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapyCaroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, et al.
Biomolecules|August 26, 2023
Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular ProfilingEmmanuel Grolleau, Julie Candiracci, Gaelle Lescuyer, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2024
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trialOlivier Bylicki, Florian Guisier, Arnaud Scherpereel, et al.
Tobacco Prevention & Cessation|July 16, 2021
Tobacco use and related behaviors among staff and students in a university hospital: A large cross-sectional surveyEmmanuel Grolleau, Véronique Fonteille, Caroline Lebourgeois, et al.
Pageof 2